Strategic Acquisition Natreon was acquired by Kerry Group in 2022 for approximately $45 million, indicating strong strategic value and potential alignment with Kerry’s broader ingredients portfolio. This suggests access to larger distribution networks and resources to scale Ayurvedic ingredient offerings.

Growth Opportunity With revenue in the low millions and a focused niche in Ayurvedic botanical ingredients for dietary supplements, personal care, food & beverage, and medical foods, there is opportunity to upsell to Kerry Group’s global customer base and co-develop higher-value, science-backed ingredient solutions.

Global Expansion The mission to bring scientifically studied Ayurvedic ingredients worldwide aligns with a global supply and regulatory readiness strategy, enabling sales plays targeting multinational supplement brands seeking compliant, evidence-based botanicals.

Product Differentiation Recent launches such as PrimaVie shilajit with organic certification underscore a track record of differentiated, quality-centric products that can be positioned as premium ingredients in modern wellness formulas.

partnership Readiness Existing tech footprint and digital presence, combined with Kerry’s distribution and resources, create a favorable environment for channel partnerships, co-marketing, and joint-venture initiatives to access new markets and expedite SKUs.